CTLA-4+ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Cancer Research

Topics

Medicine

Cancer Oncology

Immunology

Internal Medicine

Pathology And Forensic Medicine

Show all topics

DOI

10.1158/0008-5472.can-14-2788

License

CC-BY

Other Formats

PDF